natgillin/translations-raw huggingface dataset:
Each package of Kovaltry contains: one vial with powder (10 mL clear glass type 1 vial with grey halogenobutyl rubber blend stopper and aluminium seal) one pre-filled syringe with 2.5 mL (for 250 IU, 500 IU and 1000 IU) or 5 mL (for 2000 IU and 3000 IU) solvent (clear glass cylinder type 1 with grey bromobutyl rubber blend stopper)
jednu bočicu koja sadrži prašak (bočica od 10 ml od prozirnog stakla tipa 1 sa sivim čepom od halogenobutilne gume i aluminijskim zatvaračem) jednu napunjenu štrcaljku s 2,5 ml (za 250 IU, 500 IU i 1000 IU) ili 5 ml (za 2000 IU i 3000 IU) otapala (tijelo od prozirnog stakla tipa 1 sa sivim čepom od bromobutilne gume)
Each package of Kovaltry contains: one vial with reconstitution cap (Bio-Set System), containing powder (10 mL clear glass type 1 vial with grey halogenobutyl rubber blend stopper plus reconstitution cap) one pre-filled syringe with 2.5 mL (for 250 IU, 500 IU and 1000 IU) or 5 mL (for 2000 IU and 3000 IU) solvent (clear glass cylinder type 1 with grey bromobutyl rubber blend stopper)
Pakiranje lijeka Kovaltry sadrži: jednu bočicu sa zatvaračem za rekonstituciju (Bio-Set sustav) koja sadrži prašak (bočica od 10 ml od prozirnog stakla tipa 1 sa sivim čepom od halogenobutilne gume i zatvaračem za rekonstituciju) jednu napunjenu štrcaljku s 2,5 ml (za 250 IU, 500 IU i 1000 IU) ili 5 ml (za 2000 IU i 3000 IU) otapala (tijelo od prozirnog stakla tipa 1 sa sivim čepom od bromobutilne gume)
Each patch consists of a combination of a removable, transparent, split release liner, a functional layer containing drug-in- adhesive (DIA) matrix, and a protective backing layer.
Jedan transdermalni flaster sastoji se od sljedeće kombinacije: odvojive, transparentne zaštitne folije koja se može skinuti, funkcionalnog sloja koji sadrži lijek u adhezivnom matriksu i zaštitnog potpornog sloja.
Each patch is 14 cm x 20 cm (280 cm2) and consists of an adhesive side containing the active substance and an outer surface backing layer.
Jedan flaster ima dimenzije 14 cm x 20 cm (280 cm2) i sastoji se od ljepljive strane koja sadrži djelatnu tvar i vanjskog potpornog sloja.
Each patch is packed in a separate sachet.
Svaki flaster pakiran je u zasebnu vrećicu.
Each patch is sealed in a pouch that protects it until you are ready to put it on.
Svaki je flaster zapakiran u vrećicu koja ga štiti do trenutka kada ste spremni postaviti ga.
Each patch is sealed in a sachet that protects it until you are ready to put it on.
Svaki je flaster zapakiran u vrećicu koja ga štiti do trenutka kada ste spremni postaviti ga.
Each patch is sealed in its own protective pouch.
Svaki je flaster zapakiran u vlastitu zaštitnu vrećicu.
Each patch of 10 cm2 contains 4.5 mg of rotigotine.
Jedan flaster površine 10 cm2 sadrži 4,5 mg rotigotina.
Each patch of 20 cm2 contains 9.0 mg of rotigotine.
Jedan flaster površine 20 cm2 sadrži 9 mg rotigotina.
Each patch releases 8 mg of rotigotine per 24 hours.
Jedan flaster oslobađa 2 mg rotigotina u 24 sata.
Each patient (or patient’s caregiver) should be reminded to read the Package Leaflet included in the Invirase Package.
Svakom bolesniku (ili njegovatelju bolesnika) treba napomenuti da pročita Uputu o lijeku priloženu u pakiranju lijeka Invirase.
Each patient and investigator was asked to rate the patient’s method of pain control as either poor, fair, good, or excellent.
Svaki bolesnik i ispitivač trebao je ocijeniti metodu kontrole boli bolesnika kao lošu, osrednju, dobru ili odličnu.
Each patient had to have at least 90 seizures in the month prior to study entry.
Svaki je bolesnik morao imati najmanje 90 napadaja u mjesecu prije ulaska u ispitivanje.
Each patient ranked their pain intensity on an 11-point scale.
Svaki je bolesnik rangirao svoj intenzitet boli na skali s 11 bodova.
Each patient should also receive an anticoagulant (a medicine to prevent the formation of blood clots) for at least the first five months of treatment, after careful assessment of the patient’s individual risk.
Osim toga, svaki bolesnik treba primati antikoagulans (lijek za sprječavanje nastanka krvnih ugrušaka) tijekom najmanje prvih pet mjeseci liječenja, a nakon pažljive procjene rizika za svakog pojedinog bolesnika.
Each patient should be up-titrated to the highest individually tolerated dose, which can range from 200 micrograms given twice daily to 1,600 micrograms given twice daily (individualised maintenance dose).
Svakom bolesniku treba polako povećavati dozu do najveće doze koju može podnositi, što može biti u rasponu od 200 mikrograma uzeto dva puta dnevno do 1600 mikrograma uzeto dva puta dnevno (individualizirana doza održavanja).
Each patient should take the medicine at the same time each day with respect to food, such as always before or always after a meal.
Svaki bolesnik treba uzimati lijek u isto vrijeme svakog dana u odnosu na hranu, primjerice uvijek prije ili uvijek nakon obroka.
Each patient then used the identified dose of Instanyl or placebo to treat breakthrough pain.
Svaki je bolesnik zatim koristio identificiranu dozu lijeka Instanyl ili placebo za liječenje probojne boli.
Each patient-specific pack contains a sufficient amount of vials to dose each patient with 1 x 1012 gc/kg body weight.
Svako pakiranje specifično za bolesnika sadrži dovoljnu količinu bočica za primjenu doze od 1 x 1012 gk/kg tjelesne težine bolesnika.
Each patient-specific pack contains a sufficient amount of vials to dose each patient with 1 x 1012 LPLS447X gc/kg bodyweight.
Svako za bolesnika specifično pakiranje sadrži dovoljnu količinu bočica za primjenu doze od 1 x 1012 LPLS447X gk/kg tjelesne težine bolesnika.
Each patient’s CFA-72h during placebo treatment was used as their no-treatment CFA-72h value.
CFA- 72 h svakog bolesnika tijekom liječenja placebom korišten je kao njihova vrijednost CFA-72 h bez liječenja.
Each pen can be used once only.
Jedna brizgalica se može koristiti samo jedanput.
Each pen contains 0.13 mg sodium.
Jedna brizgalica sadrži 0,13 mg natrija .
Each pen contains 0.13 mg sodium.
Jedna brizgalica sadrži 0,13 mg natrija.
Each pen contains 0.5 mL of solution.
Svaka napunjena brizgalica sadrži 0,5 ml otopine.
Each pen contains 18 million IU.
Jedna brizgalica sadrži 18 milijuna IU.
Each pen contains 28 doses of 20 micrograms (per 80 microliters).
Jedna brizgalica sadrži 28 doza po 20 mikrograma (u 80 mikrolitara).
Each pen contains 3 mL of solution for injection (equivalent to 300 units).
Jedna brizgalica sadrži 3 ml otopine za injekciju, (što odgovara 300 jedinica).
Each pen contains 3 ml of solution for injection, equivalent to 300 IU insulin.
Jedna brizgalica sadrži 3 ml otopine za injekciju, što odgovara 300 IU inzulina.
Each pen contains 3 ml of solution for injection, equivalent to 300 Units.
Jedna brizgalica sadrži 3 ml otopine za injekciju, što odgovara 300 jedinica.
Each pen contains 3 ml solution, equivalent to 300 Units.
Jedna napunjena brizgalica sadrži 3 ml otopine (što odgovara 300 jedinica).
Each pen contains 30 million IU.
Jedna brizgalica sadrži 30 milijuna IU.
Each pen contains 60 million IU.
Jedna brizgalica sadrži 60 milijuna IU.
Each pen contains 600 units of insulin lispro in 3 ml solution.
Jedna brizgalica sadrži 600 jedinica inzulina lispro u 3 ml otopine.
Each pen contains less than 1 mmol (23 mg) sodium and is therefore considered essentially “sodium-free”.
Svaka brizgalica sadrži manje od 1 mmol (23 mg) natrija te se stoga smatra da sadrži „zanemarive količine natrija“.
Each pen contains less than 1 mmol sodium (23 mg). i.e. it is essentially “sodium-free”.
Jedna brizgalica sadrži manje od 1 mmol natrija (23 mg), tj. "zanemarive količine natrija".
Each pen delivers 30 mg albiglutide per 0.5 ml dose following reconstitution.
Nakon rekonstitucije, jedna brizgalica osigurava primjenu 30 mg albiglutida po dozi od 0,5 ml.
Each pen delivers 50 mg albiglutide per 0.5 ml dose following reconstitution.
Nakon rekonstitucije, jedna brizgalica osigurava primjenu 50 mg albiglutida po dozi od 0,5 ml.
Each pen delivers one dose only.
Jedna brizgalica isporučuje samo jednu dozu.
Each pen delivers only one dose.
Jednom brizgalicom može se primijeniti samo jedna doza.
Each pen has 60 doses to provide 30 days of twice–a– day injections.
U svakoj brizgalici nalazi se 60 doza lijeka, što omogućuje primjenu dvije injekcije na dan tijekom 30 dana.
Each pen is intended for a maximum four-week use period and must then be discarded.
Svaka brizgalica namijenjena je za uporabu tijekom najdulje 4 tjedna, nakon čega se mora zbrinuti.
Each pen is intended for a maximum four-week use period and must then be discarded.
Svaka brizgalica namijenjena je za uporabu tijekom najdulje četiri tjedna, nakon čega se mora zbrinuti.
Each pen should be used by one person only and is for single use.
Svaku brizgalicu smije koristiti samo jedna osoba i namijenjena je za jednokratnu uporabu.
Each Pioglitazone Accord 15 mg tablet contains 15 mg of pioglitazone (as hydrochloride).
Jedna Pioglitazone Accord 15 mg tableta sadrži 15 mg pioglitazona (u obliku klorida).
Each Pioglitazone Accord 30 mg tablet contains 30 mg of pioglitazone (as hydrochloride).
Jedna Pioglitazone Accord 30 mg tableta sadrži 30 mg pioglitazona (u obliku klorida).
Each Pioglitazone Accord 45 mg tablet contains 45 mg of pioglitazone (as hydrochloride).
Jedna Pioglitazone Accord 45 mg tableta sadrži 45 mg pioglitazona (u obliku klorida).
Each pipette of Activyl delivers:
Svaka pipeta Activyla sadrži:
Each pipette of Activyl delivers:
Svaka pipeta sadrži:
Each pipette of Activyl Tick Plus delivers:
Svaka pipeta Activyl Tick Plus sadrži::
Each Plegridy pre-filled pen is provided with the needle pre-attached.
Svaka Plegridy napunjena brizgalica je dostavljena s već pričvršćenom iglom.
Each Plegridy pre-filled syringe is provided with the needle pre-attached.
Svaka Plegridy napunjena štrcaljka je dostavljena s već pričvršćenom iglom.
Each powder vial contains 250, 500, 1000 or 2000 IU of simoctocog alfa.
Svaka bočica s praškom sadrži 250, 500, 1000 ili 2000 IU tvari simoktokog alfa.
Each powder vial contains 500 units of C1 inhibitor.
Jedna bočica praška sadrži 500 jedinica inhibitora C1.
Each powder vial contains nominally 250, 500, 1000, or 1500 IU octocog alfa.
Jedna bočica s praškom sadrži nominalno – 250, 500, 1000 ili 1500 IU oktokoga alfa.
Each pre- filled pen delivers 150 IU (equivalent to 11 micrograms) in 0.25 ml.
Svaka napunjena brizgalica osigurava primjenu 150 IU (što odgovara 11 mikrograma) u 0,25 ml.
Each pre- filled pen delivers 225 IU (equivalent to 16.5 micrograms) in 0.375 ml.
Svaka napunjena brizgalica osigurava primjenu 225 IU (što odgovara 16,5 mikrograma) u 0,375 ml.
Each pre- filled pen delivers 300 IU (equivalent to 22 micrograms) in 0.5 ml.
Svaka napunjena brizgalica osigurava primjenu 300 IU (što odgovara 22 mikrograma) u 0,5 ml.
Each pre- filled pen delivers 450 IU (equivalent to 33 micrograms) in 0.75 ml.
Svaka napunjena brizgalica osigurava primjenu 450 IU (što odgovara 33 mikrograma) u 0,75 ml.
Each pre- filled pen delivers 75 IU (equivalent to 5.5 micrograms) in 0.125 ml.
Svaka napunjena brizgalica osigurava primjenu 75 IU (što odgovara 5,5 mikrograma) u 0,125 ml.
Each pre- filled syringe should only be used for the treatment of a single eye.
Svaka napunjena štrcaljka mora se koristiti samo za primjenu na jednom oku.
Each pre-filled multidose pen delivers 300 IU (equivalent to 22 micrograms) in 0.5 mL. recombinant human follicle stimulating hormone (r-hFSH) produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
Svaka višedozna napunjena brizgalica osigurava primjenu 300 IU (odgovara 22 mikrograma) u 0,5 ml. rekombinantan ljudski folikulo-stimulirajući hormon (r-hFSH), proizveden u stanicama jajnika kineskog hrčka (CHO stanice) dobivenih tehnologijom rekombinantne DNK.
Each pre-filled multidose pen delivers 450 IU (equivalent to 33 micrograms) in 0.75 mL. recombinant human follicle stimulating hormone (r-hFSH) produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
Svaka višedozna napunjena brizgalica osigurava primjenu 450 IU (odgovara 33 mikrograma) u 0,75 ml. rekombinantan ljudski folikulo-stimulirajući hormon (r-hFSH), proizveden u stanicama jajnika kineskog hrčka (CHO stanice) dobivenih tehnologijom rekombinantne DNK.
Each pre-filled pen (3 mL) contains 300 units (U) of insulin degludec.
Jedna napunjena brizgalica (3 ml) sadrži 300 jedinica (U) degludek inzulina.
Each pre-filled pen (3 mL) contains 300 units (U) of insulin degludec/insulin aspart.
Jedna napunjena brizgalica (3 ml) sadrži 300 jedinica (U) degludek inzulina/aspart inzulina.
Each pre-filled pen (3 mL) contains 600 units (U) of insulin degludec.
Jedna napunjena brizgalica (3 ml) sadrži 600 jedinica (U) degludek inzulina.
Each pre-filled pen (CLEARCLICK) is reconstituted with the solvent provided in the two-chamber cartridge (water for injections) for administration of up to 0.5 ml of solution.
Svaka napunjena brizgalica (CLEARCLICK) rekonstituira se s otapalom (voda za injekcije) koje se nalazi u ulošku s dvije komore, za primjenu najviše 0,5 ml otopine.
Each pre-filled pen contains 0.5 ml of solution.
Jedna napunjena brizgalica sadrži 0,5 ml otopine.
Each pre-filled pen contains 0.5 ml solution.
Jedna napunjena brizgalica sadrži 0,5 ml otopine.
Each pre-filled pen contains 0.75 mg of dulaglutide in 0.5 ml solution
Jedna napunjena brizgalica sadrži 0,75 mg dulaglutida u 0,5 ml otopine.
Each pre-filled pen contains 0.75 mg of dulaglutide* in 0.5 ml solution.
Jedna napunjena brizgalica sadrži 0,75 mg dulaglutida* u 0,5 ml otopine.
Each pre-filled pen contains 1.5 mg of dulaglutide in 0.5 ml solution
Jedna napunjena brizgalica sadrži 1,5 mg dulaglutida u 0,5 ml otopine.
Each pre-filled pen contains 1.5 mg of dulaglutide* in 0.5 ml solution.
Jedna napunjena brizgalica sadrži 1,5 mg dulaglutida* u 0,5 ml otopine.
Each pre-filled pen contains 1.61 mg parathyroid hormone corresponding to 14 doses.
Svaka napunjena brizgalica sadrži 1,61 mg paratireoidnog hormona što odgovara 14 doza.
Each pre-filled pen contains 10 micrograms of darbepoetin alfa in 0.4 ml (25 µg/ml).
Jedna napunjena brizgalica sadrži 10 mikrograma darbepoetina alfa u 0,4 ml (25 µg/ml).
Each pre-filled pen contains 100 micrograms of darbepoetin alfa in 0.5 ml (200 µg/ml).
Jedna napunjena brizgalica sadrži 100 mikrograma darbepoetina alfa u 0,5 ml (200 µg/ml).
Each pre-filled pen contains 100 micrograms of peginterferon alfa-2b as measured on a protein basis.
Jedna napunjena brizgalica sadrži 100 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
Each pre-filled pen contains 100 micrograms of peginterferon alfa-2b measured on a protein basis.
Jedna napunjena brizgalica sadrži 100 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
Each pre-filled pen contains 120 micrograms of peginterferon alfa-2b as measured on a protein basis.
Jedna napunjena brizgalica sadrži 120 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
Each pre-filled pen contains 120 micrograms of peginterferon alfa-2b measured on a protein basis.
Jedna napunjena brizgalica sadrži 120 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
Each pre-filled pen contains 125 mg of abatacept in one mL.
Jedna napunjena brizgalica sadrži 125 mg abatacepta u jednom ml.
Each pre-filled pen contains 125 micrograms of peginterferon beta-1a in 0.5 mL.
Jedna napunjena brizgalica sadrži 125 mikrograma peginterferona beta-1a u 0,5 ml.
Each pre-filled pen contains 125 micrograms of peginterferon beta-1a in 0.5mL.
Jedna napunjena brizgalica sadrži 125 mikrograma peginterferona beta-1a u 0,5 ml.
Each pre-filled pen contains 130 micrograms of darbepoetin alfa in 0.65 ml (200 µg/ml).
Jedna napunjena brizgalica sadrži 130 mikrograma darbepoetina alfa u 0,65 ml (200 µg/ml).
Each pre-filled pen contains 140 mg of evolocumab in 1 mL of solution.
Svaka napunjena brizgalica sadrži 140 mg evolokumaba u 1 ml otopine.
Each pre-filled pen contains 15 micrograms of darbepoetin alfa in 0.375 ml (40 µg/ml).
Jedna napunjena brizgalica sadrži 15 mikrograma darbepoetina alfa u 0,375 ml (40 µg/ml).
Each pre-filled pen contains 150 mg alirocumab in 1 ml solution (150 mg/ml).
Jedna napunjena brizgalica sadrži 150 mg alirokumaba u 1 ml otopine (150 mg/ml).
Each pre-filled pen contains 150 mg of daclizumab in 1 mL solution for injection.
Jedna napunjena brizgalica sadrži 150 mg daklizumaba u 1 ml otopine za injekciju.
Each pre-filled pen contains 150 mg secukinumab* in 1 ml.
Svaka napunjena brizgalica sadrži 150 mg sekukinumaba* u 1 ml.
Each pre-filled pen contains 150 mg secukinumab.
Svaka napunjena brizgalica sadrži 150 mg sekukinumaba.
Each pre-filled pen contains 150 micrograms of darbepoetin alfa in 0.3 ml (500 µg/ml).
Jedna napunejna brizgalica sadrži 150 mikrograma darbepoetina alfa u 0,3 ml (500 µg/ml).
Each pre-filled pen contains 150 micrograms of peginterferon alfa-2b as measured on a protein basis.
Jedna napunjena brizgalica sadrži 150 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
Each pre-filled pen contains 150 micrograms of peginterferon alfa-2b measured on a protein basis.
Jedna napunjena brizgalica sadrži 150 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
Each pre-filled pen contains 2 mg of exenatide.
Jedna napunjena brizgalica sadrži 2 mg eksenatida.
Each pre-filled pen contains 20 micrograms of darbepoetin alfa in 0.5 ml (40 µg/ml).
Jedna napunjena brizgalica sadrži 20 mikrograma darbepoetina alfa u 0,5 ml (40 µg/ml).
Each pre-filled pen contains 200 mg certolizumab pegol in one ml.
Jedna napunjena brizgalica sadrži 200 mg certolizumabpegola u jednom ml.
Each pre-filled pen contains 200 mg of certolizumab pegol in one ml.
Jedna napunjena brizgalica sadrži 200 mg certolizumabpegola u jednom ml.
Each pre-filled pen contains 22 micrograms, corresponding to 6 million International Units (IU) of interferon beta-1a.
Svaka napunjena brizgalica sadrži 22 mikrograma što odgovara 6 milijuna internacionalnih jedinica (IU) interferona beta-1a.
Each pre-filled pen contains 250 micrograms choriogonadotropin alfa in 0.5 mL (equivalent to approximately 6,500 International Units, IU).
Jedna napunjena brizgalica sadrži 250 mikrograma koriogonadotropina alfa u 0,5 ml (što odgovara približno 6500 internacionalnih jedinica, IU).
Each pre-filled pen contains 250 micrograms choriogonadotropin alfa* (equivalent to approximately 6,500 IU). recombinant human chorionic gonadotropin, r-hCG produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.
Jedna napunjena brizgalica sadrži 250 mikrograma koriogonadotropina alfa* (što odgovara približno 6500 IU). rekombinantni humani korionski gonadotropin, r-hCG proizveden na stanicama jajnika kineskog hrčka (CHO) tehnologijom rekombinantne DNK.
Each pre-filled pen contains 30 micrograms of darbepoetin alfa in 0.3 ml (100 µg/ml).
Jedna napunjena brizgalica sadrži 30 mikrograma darbepoetina alfa u 0,3 ml (100 µg/ml).
Each pre-filled pen contains 300 international units of human insulin in 3 ml solution for injection.
Jedna napunjena brizgalica sadrži 300 internacionalnih jedinica humanog inzulina u 3 ml otopine za injekciju.
Each pre-filled pen contains 300 international units of human insulin in 3 ml suspension for injection.
Jedna napunjena brizgalica sadrži 300 internacionalnih jedinica humanog inzulina u 3 ml suspenzije za injekciju.
Each pre-filled pen contains 300 micrograms of darbepoetin alfa in 0.6 ml (500 µg/ml).
Jedna napunjena brizgalica sadrži 300 mikrograma darbepoetina alfa u 0,6 ml (500 µg/ml).
Each pre-filled pen contains 40 mg of sucrose per 0.5 ml.
Jedna napunjena brizgalica sadrži 40 mg saharoze u 0,5 ml.
Each pre-filled pen contains 40 micrograms of darbepoetin alfa in 0.4 ml (100 µg/ml).
Jedna napunjena brizgalica sadrži 40 mikrograma darbepoetina alfa u 0,4 ml (100 µg/ml).
Each pre-filled pen contains 44 micrograms, corresponding to 12 million International Units (IU) of interferon beta-1a.
Svaka napunjena brizgalica sadrži 44 mikrograma što odgovara 12 milijuna internacionalnih jedinica (IU) interferona beta-1a.
Each pre-filled pen contains 50 mg etanercept in 1 ml.
Jedna napunjena brizgalica sadrži 50 mg etanercepta u 1 ml.
Each pre-filled pen contains 50 mg of etanercept in a total volume of 1 ml.
Svaka napunjena brizgalica sadrži 50 mg etanercepta u ukupnom volumenu od 1 ml.
Each pre-filled pen contains 50 mg of etanercept.
Svaka napunjena brizgalica sadrži 50 mg etanercepta.
Each pre-filled pen contains 50 microgram of peginterferon alfa-2b as measured on a protein basis.
Jedna napunjena brizgalica sadrži 50 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
Each pre-filled pen contains 50 micrograms of darbepoetin alfa in 0.5 ml (100 µg/ml).
Jedna napunjena brizgalica sadrži 50 mikrograma darbepoetina alfa u 0,5 ml (100 µg/ml).
Each pre-filled pen contains 50 micrograms of peginterferon alfa-2b measured on a protein basis.
Jedna napunjena brizgalica sadrži 50 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
Each pre-filled pen contains 500 micrograms of darbepoetin alfa in 1 ml (500 µg/ml).
Jedna napunjena brizgalica sadrži 500 mikrograma darbepoetina alfa u 1 ml (500 µg/ml).
Each pre-filled pen contains 60 micrograms of darbepoetin alfa in 0.3 ml (200 µg/ml).
Jedna napunjena brizgalica sadrži 60 mikrograma darbepoetina alfa u 0,3 ml (200 µg/ml).
Each pre-filled pen contains 75 mg alirocumab in 1 ml solution (75 mg/ml).
Jedna napunjena brizgalica sadrži 75 mg alirokumaba u 1 ml otopine (75 mg/ml).
Each pre-filled pen contains 80 mg ixekizumab in 1 ml.
Jedna napunjena brizgalica sadrži 80 mg iksekizumaba u 1 ml.
Each pre-filled pen contains 80 mg of ixekizumab in 1 ml solution.
Jedna napunjena brizgalica sadrži 80 mg iksekizumaba u 1 ml otopine.
Each pre-filled pen contains 80 micrograms of darbepoetin alfa in 0.4 ml (200 µg/ml).
Jedna napunjena brizgalica sadrži 80 mikrograma darbepoetina alfa u 0,4 ml (200 µg/ml).
Each pre-filled pen contains 80 micrograms of peginterferon alfa-2b as measured on a protein basis.
Jedna napunjena brizgalica sadrži 80 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
Each pre-filled pen contains 80 micrograms of peginterferon alfa-2b measured on a protein basis.
Jedna napunjena brizgalica sadrži 80 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.
Each pre-filled pen delivers 150 IU follitropin alfa, equivalent to 11 micrograms per 0.25 ml.
Svaka napunjena brizgalica isporučuje 150 IU folitropin alfa, što odgovara 11 mikrograma u 0,25 ml.
Each pre-filled pen delivers 300 IU follitropin alfa, equivalent to 22 micrograms per 0.5 ml.
Svaka napunjena brizgalica isporučuje 300 IU folitropin alfa, što odgovara 22 mikrograma u 0,5 ml.
Each pre-filled pen delivers 450 IU follitropin alfa, equivalent to 33 micrograms per 0.75 ml.
Svaka napunjena brizgalica isporučuje 450 IU folitropin alfa, što odgovara 33 mikrograma u 0,75 ml.
Each pre-filled pen delivers 75 IU follitropin alfa, equivalent to 5.5 micrograms per 0.125 ml.
Svaka napunjena brizgalica osigurava primjenu 75 IU folitropina alfa, što odgovara 5,5 mikrograma u
Each pre-filled pen is for single use only.
Svaka napunjena brizgalica je isključivo za jednokratnu primjenu.
Each pre-filled pen of 0.5 ml contains 30 micrograms (6 million IU) of interferon beta-1a.
Jedna napunjena brizgalica s 0,5 ml otopine sadrži 30 mikrograma (6 milijuna IU) interferona beta-1a.
Each pre-filled pen of 0.5 ml solution contains 135 micrograms peginterferon alfa-2a*.
Svaka napunjena brizgalica s 0,5 ml otopine sadrži 135 mikrograma peginterferona alfa-2a*.
Each pre-filled pen of 0.5 ml solution contains 135 micrograms peginterferon alfa-2a.
Jedna napunjena brizgalica s 0,5 ml otopine sadrži 135 mikrograma peginterferona alfa-2a.
Each pre-filled pen of 0.5 ml solution contains 135or 180 micrograms peginterferon alfa-2a.
Jedna napunjena brizgalica s 0,5 ml otopine sadrži 135 ili 180 mikrograma peginterferona alfa-2a.
Each pre-filled pen of 0.5 ml solution contains 180 micrograms peginterferon alfa-2a*.
Svaka napunjena brizgalica s 0,5 ml otopine sadrži 180 mikrograma peginterferona alfa-2a*.
Each pre-filled pen of 0.5 ml solution contains 180 micrograms peginterferon alfa-2a.
Jedna napunjena brizgalica s 0,5 ml otopine sadrži 180 mikrograma peginterferona alfa-2a.